{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:46:04Z","timestamp":1789955164662,"version":"4.0.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hereditary transthyretin (ATTRv) amyloidosis caused by the V30M (<jats:italic>p. V50M<\/jats:italic>) mutation is a fatal, neuropathic systemic amyloidosis. Liver transplantation has prolonged the survival of patients and central nervous system (CNS) complications, attributed to amyloid angiopathy caused by CNS synthesis of variant transthyretin, have emerged. The study aimed to ascertain amyloid deposition within the brain in long-term ATTRv amyloidosis survivors with neurological symptoms from the CNS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 20 patients with ATTR V30M having symptoms from the CNS and a median disease duration of 16 years (8\u201325 years) were included in this study. The cognitive and peripheral nervous functions were determined for 18 patients cross-sectionally at the time of the investigation. Amyloid brain deposits were examined by [<jats:sup>18<\/jats:sup>F]flutemetamol PET\/CT. Five patients with Alzheimer's disease (AD) served as positive controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>60% of the patients with ATTRv had a pathological Z-score in the cerebellum, compared to only 20% in the patients with AD. 75% of the patients with transient focal neurological episodes (TFNEs) displayed a pathological uptake only in the cerebellum. Increased cerebellar uptake was related to an early age of onset of the ATTRv disease. 55% of the patients with ATTRv had a pathological Z-score in the global cerebral region compared to 100% of the patients with AD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Amyloid deposition within the brain after long-standing ATTRv amyloidosis is common, especially in the cerebellum. A cerebellar amyloid uptake profile seems to be related to TFNE symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.816636","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T15:17:16Z","timestamp":1646407036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors"],"prefix":"10.3389","volume":"13","author":[{"given":"Erica Irene","family":"Uneus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Wilhelmsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intissar","family":"Anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pilebro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Riklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"\u00d6gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"\u00d6green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole B.","family":"Suhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0925-4439(00)00029-6","article-title":"Alzheimer's amyloid fibrils: structure and assembly","volume":"1502","author":"Serpell","year":"2000","journal-title":"Biochim Biophys Acta."},{"key":"B2","first-page":"1","article-title":"Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden","volume":"590","author":"Andersson","year":"1976","journal-title":"Acta Med Scand Suppl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"B5","unstructured":"RowczenioD\n            WechalekarA\n          Mutations in Hereditary Amyloidosis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1021\/bi027319b","article-title":"D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?","volume":"42","author":"Hammarstrom","year":"2003","journal-title":"Biochemistry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/01.LAB.0000059937.11023.1F","article-title":"Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology","volume":"83","author":"Sekijima","year":"2003","journal-title":"Lab Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/path.2411","article-title":"Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis","volume":"216","author":"Ihse","year":"2008","journal-title":"J Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2796.1994.tb01106.x","article-title":"Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy","volume":"235","author":"Suhr","year":"1994","journal-title":"J Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/TP.0b013e31824b3749","article-title":"Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis","volume":"93","author":"Gustafsson","year":"2012","journal-title":"Transplantation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/TP.0000000000001021","article-title":"Survival after transplantation in patients with mutations other than Val30Met: extracts from the FAP world transplant registry","volume":"100","author":"Suhr","year":"2016","journal-title":"Transplantation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","article-title":"A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation","volume":"77","author":"Ando","year":"2004","journal-title":"Transplantation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/13506129.2016.1236332","article-title":"Tafamidis in hereditary ATTR amyloidosis \u2013 our experience on monitoring the ocular manifestations","volume":"23","author":"Casal","year":"2016","journal-title":"Amyloid."},{"key":"B19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1600-0420.2007.01098.x","article-title":"Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy","volume":"86","author":"Sandgren","year":"2008","journal-title":"Acta ophthalmologica."},{"key":"B20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","article-title":"CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings","volume":"86","author":"Maia","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1212\/WNL.0000000000003001","article-title":"Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis","volume":"87","author":"Sekijima","year":"2016","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1097\/TP.0000000000001975","article-title":"Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients","volume":"102","author":"Wange","year":"2018","journal-title":"Transplantation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1212\/01.WNL.0000065901.18353.AB","article-title":"Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His","volume":"60","author":"Blevins","year":"2003","journal-title":"Neurology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/13506129.2013.860895","article-title":"In vitro binding of [H]PIB to human amyloid deposits of different types","volume":"21","author":"Hellstrom-Lindahl","year":"2014","journal-title":"Amyloid."},{"key":"B25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12350-016-0638-5","article-title":"Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)","volume":"25","author":"Pilebro","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/13506129.2020.1798223","article-title":"Non-invasive detection and differentiation of cardiac amyloidosis using (99m)Tc-pyrophosphate scintigraphy and C-Pittsburgh compound B PET imaging","volume":"27","author":"Takasone","year":"2020","journal-title":"Amyloid"},{"key":"B28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaneurol.2016.0832","article-title":"Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy: an imaging-pathologic study of concept validation","volume":"73","author":"Charidimou","year":"2016","journal-title":"JAMA Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ijs.12035","article-title":"Transient focal neurological episodes, cerebral amyloid angiopathy, and intracerebral hemorrhage risk: looking beyond TIAs","volume":"8","author":"Charidimou","year":"2013","journal-title":"Int J Stroke."},{"key":"B31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/00007890-199511150-00009","article-title":"Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients","volume":"60","author":"Suhr","year":"1995","journal-title":"Transplantation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1212\/WNL.0000000000001870","article-title":"Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study","volume":"85","author":"Adams","year":"2015","journal-title":"Neurology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2967\/jnumed.108.060756","article-title":"Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging","volume":"50","author":"Koole","year":"2009","journal-title":"J Nucl Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","article-title":"Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease","volume":"50","author":"Nelissen","year":"2009","journal-title":"J Nucl Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1118\/1.3635220","article-title":"Physical performance of the new hybrid PETCT Discovery-690","volume":"38","author":"Bettinardi","year":"2011","journal-title":"Med Phys."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2967\/jnumed.112.115006","article-title":"Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data","volume":"54","author":"Lundqvist","year":"2013","journal-title":"J Nucl Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2967\/jnumed.114.142109","article-title":"Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads","volume":"55","author":"Thurfjell","year":"2014","journal-title":"J Nucl Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/13506129.2014.894908","article-title":"Gene expression profile in hereditary transthyretin amyloidosis: Differences in targeted and source organs","volume":"21","author":"Norgren","year":"2014","journal-title":"Amyloid"},{"key":"B40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","article-title":"Structural variation in amyloid-beta fibrils from Alzheimer's disease clinical subtypes","volume":"541","author":"Qiang","year":"2017","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1212\/01.wnl.0000287089.28847.b5","article-title":"Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy","volume":"70","author":"Yamashita","year":"2008","journal-title":"Neurology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF00314080","article-title":"Cerebral amyloid angiopathy in the aged","volume":"234","author":"Yamada","year":"1987","journal-title":"J Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1161\/STROKEAHA.119.024843","article-title":"Cerebellar microbleed distribution patterns and cerebral amyloid angiopathy","volume":"50","author":"Pasi","year":"2019","journal-title":"Stroke."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S0140-6736(12)61333-6","article-title":"Amyloid \u201cspells\u201d trouble","volume":"380","author":"Charidimou","year":"2012","journal-title":"Lancet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.015","article-title":"Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis","volume":"24","author":"Salvi","year":"2015","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/13506129.2019.1632829","article-title":"A case of cerebral amyloid angiopathy-type hereditary ATTR amyloidosis with Y69H (p. Y89H) variant displaying transient focal neurological episodes as the main symptom","volume":"26","author":"Yamada","year":"2019","journal-title":"Amyloid"},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/13506129.2020.1810010","article-title":"Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding","volume":"28","author":"Mitrani","year":"2021","journal-title":"Amyloid."},{"key":"B48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/13506129.2020.1760237","article-title":"Quantification of cardiac amyloid with [F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis","volume":"27","author":"Mockelind","year":"2020","journal-title":"Amyloid."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.816636\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T15:17:20Z","timestamp":1646407040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.816636\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":48,"alternative-id":["10.3389\/fneur.2022.816636"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.816636","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"article-number":"816636"}}